Ultrastructural characteristics of Cajal interstitial cells of the muscular membrane of the gallbladder wall in an experimental study of mice under the influence of ursodeoxycholic acid

Authors

DOI:

https://doi.org/10.26641/1997-9665.2020.3.9-14

Keywords:

interstitial cell of Cajal-like cells, gallbladder, ursodeoxycholic acid, mouse

Abstract

Background. The use of ursodeoxycholic acid drugs in the treatment of diseases of the hepatobiliary system is highly effective. Interstitial cell of Cajal-like cells are involved in the generation and propagation of spontaneous rhythms and, consequently, the excitability of the gallbladder. The purpose of the study was to determine the morphological changes of Interstitial cell of Cajal-like cells of muscle of the gallbladder wall of experimental mice under the action of ursodeoxy-cholic acid. Methods. The experimental study was performed on 30 mice of the BALB / c line. By the method of simple randomization, the experimental animals were divided into 2 groups: experimental (n = 17) - animals that received ursodeoxycholic acid at a dose of 100.0 mg / kg and control (n = 13) - intact (distilled water). The study was performed using a transmission electron microscope PEM-100-01 according to a standard scheme. Results. The muscular wall of the gallbladder of mice contains numerous interstitial cells in the developed endomysium, among which heteromorphic intersti-tial cell of Cajal-like cells (telocytes) were found in both study groups, containing from 2 to 8 processes, often with branches. The elongated bodies of these cells ranged in size from 8 to 30 μm. The nucleus showed signs of moderate activity, the cytoplasm contained a small number of general-purpose organelles, with the exception of numerous dense small mitochOndria and developed agranular endoplasmic reticulum. Characteristic of interstitial cell of Cajal-like cells was the presence of numerous contacts of the processes with the membrane of neighboring leiomyocytes. A significant increase in the number of interstitial cell of Cajal-like cells in the muscular membrane of the bottom and body of the gallbladder was observed after the introduction of ursodeoxycholic acid. The ultrastructural features of their nuclear and cytoplasmic activity did not differ from those of the control group of animals. Conclusion. Thus, ultrastructural analysis of samples of the muscular wall of the gallbladder wall of mice revealed a significant increase in the number of interstitial cell of Cajal-like cells in the muscular membrane of the bottom and body of the gallbladder after the introduction of ursodeoxycholic acid.

References

  1. Abaturov AE, Babych VL. [The efficacy of the use of ursodeoxycholic acid in functional disorders of the gall bladder and sphincter of Oddi in children]. World of medicine and biology. 2019;67 (1):7-11. DOI 10.26724/2079-8334-2019-1-67-7. Ukrainian.
  2. Babych VL. [Application of ursodeoxy-cholic acid in the treatment of functional disorders of the biliary system]. Modern medical technology. 2017;3(34):64-70. Ukrainian.
  3. Belousova OYu, Voloshyna LG, Hanzii OB, Вabadzhanian OM, Slobodianiuk OL. [Experience of using ursodeoxycholic acid in the therapy of biliary sludge in children]. Child's Health. 2018;13(Appendix 1. Pediatric gastroenterology and nutrition):41-9. doi: 10.22141/2224-0551.13.0.2018.131177. Ukrainian.
  4. Shutova OV, Pavlenko NV, Babadganyan ON, Solodovnichenko IG, Buksha OV. [Issues of therapy for biliary pathology in children: the choice of the optimal solution]. Child's Health. 2018;14 (Appendix 1. Pediatric gastroenterology and nutri-?ion):23-29. doi: 10.22141/2224-0551.13.0.2018.131174. Russian.
  5. Cheng K, Ashby D, Smyth RL. Ursodeox -cholic acid for cystic fibrosis-related liver disease. Cochrane Database Syst. Rev. 2017;9:СD000222. doi: 10.1002/14651858.CD000222.pub4.
  6. Efe C, Taşçilar K, Henriksson I, at al. Vali-dation of Risk Scoring Systems in Ursodeoxycholic Acid–Treated Patients With Primary Biliary Chol-angitis. American Journal of Gastroenterology. 2019;114(7):1101–1108. doi:10.14309/ajg.0000000000000290.
  7. Harms MH, van Buuren HR, Corpechot Ch, at al. Ursodeoxycholic acid therapy and liver trans-plant-free survival in patients with primary biliary cholangitis. Journal of Hepatology. 2019;71(2):357-365. https://doi.org/10.1016/j.jhep.2019.04.001.
  8. Bodeа N, Grebeb A, Kerksiekc А at al. Ursodeoxycholic acid impairs atherogenesis and promotes plaque regression by cholesterol crystal dissolution in mice. Biochemical and Biophysical Research Communications. 2016;478(1):356–62. doi: 10.1016/j.bbrc.2016.07.047.
  9. Pearson T, Caporaso JG, Yellowhair M et al. Abstract A18: Gut microbiota changes in respo?- se to treatment with ursodeoxycholic acid (UDCA). Cancer Res. 2017;77(3 Suppl):A18. doi: 10.1158/1538-7445.CRC16-A18.
  10. Tabibian JH, Lindor KD. Ursodeoxycholic Acid Treatment in Primary Sclerosing Cholangitis. Primary Sclerosing Cholangitis. 2017. doi:10.1007/978-3-319-40908-5_11.
  11. Lang SM, Ortmann J, Rostig S, Schiffl H. Ursodeoxycholic acid attenuates hepatotoxicity of multidrug treatment of mycobacterial infections: A prospective pilot study. Int J Mycobacteriol. 2019;8:89-92. doi:10.4103/ijmy.ijmy_159_18.
  12. Abaturov OE, Babych VL. [Drug modulation of activity of microRNA generation in functional disorders of the gallbladder and Oddi's sphincter in children]. Child's Health. 2019;2(14):53-59. doi: 10.22141/2224-0551.14.2.2019.165544. Ukrainian.
  13. Abaturov AE, Babych VL. Influence ofcholeretic therapy on the microRNA-4714-3p expression level in children with functional disor-?ers of the gallbladder and Оddi's sphincter. Medicni perspektivi. 2019;24(4):43-50. https://doi.org/10.26641/2307-0404.2019.4.189196.
  14. Abaturov AE, Vysochyna IL, Babych VL, Dosenko VE. Regulation of microRNA expression level by choleretic therapy in functional disorders of the gallbladder and Оddi's sphincter in children. Wi-adomości Lekarskie. 2020;73(1):41-45. - DOI: 10.36740/WLek202001107.
  15. Abaturov AE, Babуch VL, Bondarenko NS, Bondarenko OO, Lievykh AE, Tverdokhlib IV. [Morphological evaluation of the effects of ursodeoxycholic acid on muscular layer of the gallbladder wall of the mice]. Morphologia. 2020;14(2):7-16. DOI: 10.26641/1997-9665.2020.2.7-16. Ukrainian.
  16. Housset Ch, Chretien Y, Debray D, Chi-gnard N. Functions of the Gallbladder. Comprehen-sive Physiology. 2016;6(3):1549-1577. DOI: 10.1002/cphy.c150050.
  17. Ding R, Wei J, Xu J. Gallbladder interstitial
  18. Cajal-like cells and gallbladder contractility in pa-tients with cholelithiasis: a prospective study. Folia Histochem Cytobiol. 2019;57(2):94-100. doi: 10.5603/FHC.a2019.0011. Epub 2019 Jun 25.
  19. Lavoie B, Balemba OB, Nelson MT, Ward SM, Mawe GM. Morphological and physiological evidence for interstitial cell of Cajal-like cells in the guinea pig gallbladder. J Physiol. 2007 Mar 1;579(Pt 2):487-501. DOI: 10.1113/jphysiol.2006.122861
  20. Law of Ukraine. On the protection of animals from cruelty [Electronic resource]. Infor-?ation of the Verkhovna Rada of Ukraine (VVR). 2006. Access mode: http://zakon1.rada.gov.ua/laws/show/3447-15. Ukrainian.
  21. European Convention for the Protection of Vertebrate Animals Used for Experimental and Oth-er Scientific Purposes. 1986. European Treaty Series 123. Strasbourg, France: Council of Europe.
  22. Kuo J. Electron microscopy: methods and protocols. Totowa, New Jersey: Humana Press Inc, 2007. 608 p.

How to Cite

Abaturov, O. E., Babуch V. L., & Tverdokhlib, I. V. (2020). Ultrastructural characteristics of Cajal interstitial cells of the muscular membrane of the gallbladder wall in an experimental study of mice under the influence of ursodeoxycholic acid. Морфологія / Morphologia / Morfologìâ, 14(3), 9–14. https://doi.org/10.26641/1997-9665.2020.3.9-14

Issue

Section

Статті